MétaCan
Menu
Back to cohort
Record W2239756475 · doi:10.11124/jbisrir-2015-2411

The effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review protocol

2015· review· en· W2239756475 on OpenAlex
Eng Whui Poh, Alexa McArthur

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

aboutThe title or abstract carries a Canadian signal from the geographic lexicon.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueThe JBI Database of Systematic Reviews and Implementation Reports · 2015
Typereview
Languageen
FieldMedicine
TopicPharmaceutical Practices and Patient Outcomes
Canadian institutionsnot available
Fundersnot available
KeywordsMedicinePharmacistMedical prescriptionFamily medicineLegislationMEDLINEProtocol (science)Drug Utilization ReviewPatient safetyPharmacyMedical emergencyNursingAlternative medicineHealth care

Abstract

fetched live from OpenAlex

Review question/objective The objective of this review is to determine the effects of pharmacist prescribing in the hospital setting. More specifically, the objectives are to quantitatively analyze the effectiveness of pharmacist prescribing on patient outcomes, including, but not limited to, the reduction of error rates and adverse events related to medication prescription in patients who present to hospital, either in the inpatient or outpatient setting. Background For conditions that can be medically managed, diagnosis is followed by prescribing of medications to treat a condition or alleviate symptoms associated with it. Traditionally, the act of prescribing has been mainly associated with medical practitioners. Non-medical prescribing is the extension of prescriptive rights provided to certain other professions apart from doctors, including nurses, pharmacists, optometrists and podiatrists. It was originally introduced to allow a more flexible system for the prescribing, supply and administration of medications in order to help improve patients' access to medications and ease the burden on general practitioners.1,2 Nurse prescribing was first introduced in the United States of America in 1969.3 In the last two decades, legislation changes have also occurred in various countries around the world to allow for non-medical prescribing.3-5 Pharmacist prescribing is currently legal in many countries, including Canada, New Zealand, the United Kingdom (UK) and the United States of America.2,6 In the UK, supplementary prescribing was first introduced in 2003, followed by independent prescribing in 2006.7 Different models of pharmacist prescribing have been described in the literature.1,5,6 They include independent, dependent and collaborative prescribing. In independent prescribing, pharmacists are responsible for the assessment, diagnosis and clinical management of patients. Dependent prescribing places more restrictions on the activity using protocols or formularies. The different types of dependent prescribing include: Prescribing by protocol: a written guideline (protocol) describes in explicit detail the activities that may be performed by the non-medical practitioner. This protocol includes the types of diseases and drug classes in which the practitioner may prescribe. Patient group directions: a written direction relating only to supply and administration of a prescription medicine. Prescribing by formulary: a limited list of medicines with limitations on prescribing. Prescribing by patient referral: patients are referred by a physician for specific drug therapy management or to achieve a defined therapeutic outcome. Repeat prescribing: medication-refill services in clinics for patients who require new continuing prescriptions prior to their next available appointment with their physician. Supplementary prescribing: a voluntary partnership between the physician and pharmacist, where the physician undertakes the initial assessment and the supplementary prescriber (pharmacist) prescribes in accordance with the care plan which has been agreed by the physician and patient. In collaborative prescribing, there is a cooperative practice relationship between the pharmacist and physician, where the pharmacist may prescribe medications. The physician diagnoses and makes initial treatment decisions for the patient while the pharmacist selects, monitors, modifies, continues or discontinues the treatment as appropriate. While systematic reviews on nurse prescribing are available,8,9 there are currently no systematic reviews available to quantify the effects of pharmacist prescribing in the hospital setting. One review published in 2011 assessed the contribution of prescribing by nurses and allied health professionals, but this was limited to the primary care setting.3 In 2004, a review focusing on pharmacist prescribing was published, and included prescribing in both the community and hospital setting.10 This review identified only four studies with an experimental design and concluded that additional research was needed to establish the validity of pharmacist prescribing. In a review which evaluated the impact of pharmacists on mental health, some studies involving pharmacist prescribing were included but were not the main focus of the review.11 Other published reviews which have included pharmacist prescribing mainly relate to descriptions of its current practice (including existing policies and procedures) in a specific country or region, barriers to its successful implementation, or the perspectives of pharmacist prescribers, other healthcare professionals or patients on pharmacist prescribing.2,6,12 A systematic review on the effects of pharmacist prescribing on patient outcomes in the hospital setting is therefore warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.008
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.176
Threshold uncertainty score0.930

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0150.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0050.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.179
GPT teacher head0.513
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it